Friday, December 23, 2016

BRIEF-Strongbridge Biopharma announces acquisition of U.S. rights to Keveyis from Taro

* Strongbridge Biopharma Plc says taro is also eligible to

receive additional future payments upon achievement of certain

sales unit milestones

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)